ALung Technologies recently announced the initiation of patient enrollment in its VENT-AVOID trails with the Minneapolis Heart Institute Foundation. The trial is pivotal in validating the safety and efficacy of the Hemolung Respiratory Assist System for COPD patients who require ventilatory support.
Recent Posts
A (Dog’s) Day in the Life at UPMC Enterprises
I’m a simple man; I need food, water, treats, and enough stimulation and hard work …
Read More →
The Benefits of Retrospectives
Across the world, Agile teams use retrospectives (‘retros’) to look back and discuss their progress …
Read More →